New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (ω) receptor subtypes

Psychopharmacology

Volumn 146, Issue 2, 1999, Pages 205-213

  Griebel, Guy ^a   Perrault, Ghislaine ^a   Letang, Valérie ^a   Granger, Patrick ^a   Avenet, Patrick ^a   Schoemaker, Hans ^a   Sanger, David J ^a  

^a SANOFI   (France)

Author keywords

CCT; Anxiety; Benzodiazepine; BZ ( ) receptor; Convulsions; Diazepam; In vivo binding; Mice; Myorelaxation; Sedation; Zolpidem

Indexed keywords

BENZODIAZEPINE; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; BETA CARBOLINE 3 CARBOXYLIC ACID BUTYL ESTER; BETA CARBOLINE DERIVATIVE; DIAZEPAM; FLUMAZENIL; ISONIAZID; PENTETRAZOLE; RECEPTOR SUBTYPE; ZOLPIDEM;

ANIMAL MODEL; ANXIETY NEUROSIS; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONVULSION; DRUG EFFECT; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY;

ANIMALS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; BENZODIAZEPINES; BINDING, COMPETITIVE; CARBOLINES; DIAZEPAM; FLUMAZENIL; GABA ANTAGONISTS; HYPNOTICS AND SEDATIVES; LIGANDS; MALE; MICE; MICE, INBRED BALB C; MOTOR ACTIVITY; MUSCLE RELAXANTS, CENTRAL; PATCH-CLAMP TECHNIQUES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A;

EID: 0032863732     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130051108     Document Type: Article

References (34)

1. 1) subtype. J Pharmacol Exp Ther 245:1033-1041
2. A receptors. J Recept Signal Transduct Res 17:99-113
3. 1 receptor subtype specific antagonist. Med Chem Res 5:710-718
4. Depoortere H, Zivkovic B, Lloyd KG, Sanger DJ, Perrault G, Langer SZ, Bartholini G (1986) Zolpidem, a novel non-benzodiazepine hypnotic: I. neuropharmacological and behavioral effects. J Pharmacol Exp Ther 237:649-658
5. A receptor. Eur J Pharmacol 246:283-287
6. Fleury C (1957) Nouvelle technique pour mesurer l'effort musculaire de la souris, dite test de l'agrippement. Arch Sci (Geneva) 10:107-113
7. 3H]-Ro15-1788. Life Sci 37:345-355
8. Griebel G, Sanger DJ, Perrault G (1996a) The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands. Psychopharmacology 124:245-254
9. Griebel G, Sanger DJ, Perrault G (1996b) Further evidence for differences between non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands in murine models of "state" and "trait" anxiety. Neuropharmacology 35:1081-1091
10. Griebel G, Sanger DJ, Perrault G (1996c) The Mouse Defense Test Battery: evaluation of the effects of non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands. Behav Pharmacol 7:560-572
11. Jones GH, Schneider C, Schneider HH, Seidler J, Cole BJ, Stephens DN (1994) Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies. Psychopharmacology 114:191-199
12. Langer SZ, Arbilla S (1988) Imidazopyridines as a tool for the characterization of benzodiazepine receptors: a proposal for a pharmacological classification as omega receptor subtypes. Pharmacol Biochem Behav 29:763-766
13. Lippa AS, Coupet J, Greenblatt EN, Klepner CA, Beer B (1979) A synthetic non-benzodiazepine ligand for benzodiazepine receptors: a probe for investigating neuronal substrates of anxiety. Pharmacol Biochem Behav 11:99-106
14. Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99-113
15. A benzodiazepine receptor heterogeneity: neurophysiological implications. Neuropharmacology 34:245-254
16. Mao CC, Guidotti A, Costa E (1975) Evidence for an involvement of GABA in the mediation of the cerebellar cGMP decrease and the anticonvulsant action diazepam. Naunyn-Schmiedeberg's Arch Pharmacol 289:369-378
17. Misslin R, Belzung C, Vogel E (1989) Behavioural validation of a light/dark choice procedure for testing anti-anxiety agents. Behav Process 8:119-132
18. Perrault G, Morel E, Sanger DJ, Zivkovic B (1990) Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics. Eur J Pharmacol 187:487-494
19. A receptor alpha5-subunit creates novel type II benzodiazepine receptor pharmacology. J Neurochem 54:1802-1804
20. Rodgers RJ (1997) Animal models of "anxiety": where next? Behav Pharmacol 8:477-496
21. Sanger DJ (1995) The behavioural effects of novel benzodiazepine (ω) receptor agonists and partial agonists: increases in punished responding and antagonism of the pentylenetetrazole cue. Behav Pharmacol 6:116-126
22. Sanger DJ, Zivkovic B (1988) Further behavioural evidence for the selective sedative action of zolpidem. Neuropharmacology 27:1125-1130
23. Sanger DJ, Benavides J, Perrault G, Morel E, Cohen C, Joly D, Zivkovic B (1994) Recent developments in the behavioral pharmacology of benzodiazepine (ω) receptors: evidence for the functional significance of receptor subtypes. Neurosci Biobehav Rev 18:355-372
24. Sanger DJ, Morel E, Perrault G (1996) Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem. Eur J Pharmacol 313:35-42
25. A receptors. In: Stephens DN (ed) Anxiolytic β-carbolines. Springer, Berlin, pp 62-78
26. 1 benzodiazepine receptor antagonist. Life Sci 35:2227-2236
27. A receptor subtypes. Pharmacol Rev 47:181-234
28. Sieghart W, Schuster A (1984) Affinity of various ligands for benzodiazepine receptors in rat cerebellum and hippocampus. Pharmacol Biochem Behav 33:4033-4038
29. Squires RF, Benson DI, Braestrup C, Coupet J, Klepner CA, Myers V, Beer B (1979) Some properties of brain specific benzodiazepine receptors: new evidence for multiple receptors. Pharmacol Biochem Behav 10:825-830
30. Stephens DN, Turski L, Jones GH, Steppuhn KG, Schneider HH (1993) Abecarnil: a novel anxiolytic with mixed full agonist/partial agonist properties in animal models of anxiety and sedation. Psychopharmacol Ser 11:79-95
31. Swinyard EA, Woodhead JH, White HS, Franklin MR (1989) Experimental selection, quantification, and evaluation of anticonvulsants. In: Levy R, Mattson R, Meldrum B, Penry JK, Dreifuss FE (eds) Antiepileptic drugs, third edition. Raven Press, New York, pp 85-102
32. Turski L, Stephens DN (1993) Effect of the beta-carboline abecarnil on spinal reflexes in mice and on muscle tone in genetically spastic rats: a comparison with diazepam. J Pharmacol Exp Ther 267:1215-1220
33. Zivkovic B, Perrault G, Morel E, Sanger DJ (1988) Comparative pharmacology of zolpidem and other hypnotics and sleep inducers. In: Sauvanet JP, Langer SZ, Morselli PL (eds) Imidazopyridines in sleep disorders. Raven Press, New York
34. Zivkovic B, Perrault G, Sanger D (1992) Receptor subtype-selective drugs: a new generation of anxiolytics and hypnotics. In: Mendlewitz J, Racagni G (eds) Target receptors for anxiolytics and hypnotics: from molecular pharmacology to therapeutics. Karger, Basel, pp 55-73